🇺🇸 FDA
Pipeline program

Kindolor Tosylate

KIND-2022-01

Phase 1 small_molecule terminated

Quick answer

Kindolor Tosylate for Chronic Pain is a Phase 1 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Chronic Pain
Phase
Phase 1
Modality
small_molecule
Status
terminated

Clinical trials